Pierre Belichard, Enterome CEO
July 18, 2022 03:16 AM EDTUpdated 06:52 AM
Deals

Nestlé puts down $40M, kicks off deal with gut mi­cro­bio­me spe­cial­ist to fight food al­ler­gies

Aayushi Pratap

News Reporter

French com­pa­ny En­terome, which works with the mi­cro­bio­me, has scored $40 mil­lion in a wide-rang­ing deal with its long-time Swiss in­vestor Nestlé Health Sci­ence to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times